Achieved oxygen saturations and risk for bronchopulmonary dysplasia with pulmonary hypertension in preterm infants

被引:1
|
作者
Gentle, Samuel J. [1 ]
Singh, Avinash [2 ]
Travers, Colm P. [1 ]
Nakhmani, Arie [2 ]
Carlo, Waldemar A. [1 ]
Ambalavanan, Namasivayam [1 ]
机构
[1] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Elect & Comp Engn, Birmingham, AL USA
关键词
Neonatology; Respiratory Medicine; Intensive Care Units; Neonatal; OUTCOMES; DISEASE; ASSOCIATION; MORTALITY; INDEX; HEART;
D O I
10.1136/archdischild-2024-327014
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective Characterisation of oxygen saturation (SpO(2))-related predictors that correspond with both bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH) development and survival status in infants with BPD-PH may improve patient outcomes. This investigation assessed whether (1) infants with BPD-PH compared with infants with BPD alone, and (2) BPD-PH non-survivors compared with BPD-PH survivors would (a) achieve lower SpO(2) distributions, (b) have a higher fraction of inspired oxygen (FiO(2)) exposure and (c) have a higher oxygen saturation index (OSI). Design Case-control study between infants with BPD-PH (cases) and BPD alone (controls) and by survival status within cases. Setting Single-centre study in the USA. Patients Infants born at <29 weeks' gestation and on respiratory support at 36 weeks' postmenstrual age. Exposures FiO(2) exposure, SpO(2) distributions and OSI were analysed over the week preceding BPD-PH diagnosis. Main outcomes and measures BPD-PH, BPD alone and survival status in infants with BPD-PH. Results 40 infants with BPD-PH were compared with 40 infants with BPD alone. Infants who developed BPD-PH achieved lower SpO(2) compared with infants with BPD (p<0.001), were exposed to a higher FiO(2) (0.50 vs 0.34; p=0.02) and had a higher OSI (4.3 vs 2.6; p=0.03). Compared with survivors, infants with BPD-PH who died achieved a lower SpO(2) (p<0.001) and were exposed to a higher FiO(2) (0.70 vs 0.42; p=0.049). Conclusions SpO(2)-related predictors differed between infants with BPD-PH and BPD alone and among infants with BPD-PH by survival status. The OSI may provide a non-invasive predictor for BPD-PH in preterm infants.
引用
收藏
页码:941 / 947
页数:7
相关论文
共 50 条
  • [41] Maternal preeclampsia and risk of bronchopulmonary dysplasia in preterm infants
    O'Shea, Joyce E.
    Davis, Peter G.
    Doyle, Lex W.
    PEDIATRIC RESEARCH, 2012, 71 (02) : 210 - 214
  • [42] EFFICACY OF SILDENAFIL IN INFANTS WITH BRONCHOPULMONARY DYSPLASIA AND PULMONARY HYPERTENSION
    Dillon, K. L.
    Lamba, V.
    Philip, R.
    Weems, M.
    Talati, A. J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 609 - 609
  • [43] Pulmonary hypertension in infants with bronchopulmonary dysplasia: risk factors, mortality and duration of hospitalisation
    Thodika, Fahad M. S. Arattu
    Nanjundappa, Mahesh
    Dassios, Theodore
    Bell, Aaron
    Greenough, Anne
    JOURNAL OF PERINATAL MEDICINE, 2022, 50 (03) : 327 - 333
  • [44] Pulmonary Hypertension Specific Treatment in Infants With Bronchopulmonary Dysplasia
    Kadmon, Gili
    Schiller, Ofer
    Dagan, Tamir
    Bruckheimer, Elchanan
    Birk, Einat
    Schonfeld, Tommy
    PEDIATRIC PULMONOLOGY, 2017, 52 (01) : 77 - 83
  • [45] Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia
    Levy, Philip T.
    Levin, Jonathan
    Leeman, Kristen T.
    Mullen, Mary P.
    Hansmann, Georg
    Kourembanas, Stella
    SEMINARS IN FETAL & NEONATAL MEDICINE, 2022, 27 (04):
  • [46] Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia
    Collaco, Joseph M.
    Romer, Lewis H.
    Stuart, Bridget D.
    Coulson, John D.
    Everett, Allen D.
    Lawson, Edward E.
    Brenner, Joel I.
    Brown, Anna T.
    Nies, Melanie K.
    Sekar, Priya
    Nogee, Lawrence M.
    McGrath-Morrow, Sharon A.
    PEDIATRIC PULMONOLOGY, 2012, 47 (11) : 1042 - 1053
  • [47] Soluble Klotho, a biomarker and therapeutic strategy to reduce bronchopulmonary dysplasia and pulmonary hypertension in preterm infants
    Sunil Batlahally
    Andrew Franklin
    Andreas Damianos
    Jian Huang
    Pingping Chen
    Mayank Sharma
    Joanne Duara
    Divya Keerthy
    Ronald Zambrano
    Lina A. Shehadeh
    Eliana C. Martinez
    Marissa J. DeFreitas
    Shathiyah Kulandavelu
    Carolyn L. Abitbol
    Michael Freundlich
    Rosemeire M. Kanashiro-Takeuchi
    Augusto Schmidt
    Merline Benny
    Shu Wu
    Karen K. Mestan
    Karen C. Young
    Scientific Reports, 10
  • [48] Is permissive hypercapnia associated with the development of bronchopulmonary dysplasia-associated pulmonary hypertension in preterm infants?
    Bhatia, K. S.
    Nayak, A.
    Jeffcoat, S. H.
    Carlo, W. A.
    Ambalavanan, N.
    Gentle, S.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2025, 369 : S421 - S422
  • [49] Home Oxygen Use for Preterm Infants with Bronchopulmonary Dysplasia in California
    Ejiawoko, Amarachi
    Lee, Henry C.
    Lu, Tianyao
    Lagatta, Joanne
    JOURNAL OF PEDIATRICS, 2019, 210 : 55 - +
  • [50] Reliability of Echocardiographic Indicators of Pulmonary Vascular Disease in Preterm Infants at Risk for Bronchopulmonary Dysplasia
    Carlton, Erin F.
    Sontag, Marci K.
    Younoszai, Adel
    DiMaria, Michael V.
    Miller, Joshua I.
    Poindexter, Brenda B.
    Abman, Steven H.
    Mourani, Peter M.
    JOURNAL OF PEDIATRICS, 2017, 186 : 29 - 33